These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21664768)

  • 41. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines for collaboration of industry and medical organizations in support of research and continuing medical education.
    Daher M
    J Med Liban; 2002; 50(1-2):1-2. PubMed ID: 12841304
    [No Abstract]   [Full Text] [Related]  

  • 43. Attitudes and behavior of privately-funded biomedical scientists.
    Krimsky S
    Account Res; 2009; 16(2):75-7. PubMed ID: 19353386
    [No Abstract]   [Full Text] [Related]  

  • 44. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 45. Conflict of interest in biomedical research.
    Blumenthal D
    Health Matrix Clevel; 2002; 12(2):377-92. PubMed ID: 12430361
    [No Abstract]   [Full Text] [Related]  

  • 46. Commentary: A delicate balance: weighing the effects of conflict-of-interest rules on intramural research at the National Institutes of Health.
    Gottesman MM; Jaffe HB
    Acad Med; 2010 Nov; 85(11):1660-2. PubMed ID: 20980848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accuracy of conflict-of-interest disclosures reported by physicians.
    Okike K; Kocher MS; Wei EX; Mehlman CT; Bhandari M
    N Engl J Med; 2009 Oct; 361(15):1466-74. PubMed ID: 19812403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of the federal guidelines that inform and influence relationships between physicians and industry.
    Birkhahn RH; Jauch E; Kramer DA; Nowak RM; Raja AS; Summers RL; Weber JE; Diercks DB;
    Acad Emerg Med; 2009 Aug; 16(8):776-81. PubMed ID: 19594459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgeon-industry conflict of interest: survey of opinions regarding industry-sponsored educational events and surgeon teaching: clinical article.
    DiPaola CP; Dea N; Dvorak MF; Lee RS; Hartig D; Fisher CG
    J Neurosurg Spine; 2014 Mar; 20(3):313-21. PubMed ID: 24359001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Restrictions on interactions between doctors and industry could ultimately hurt patients.
    Kimmelstiel C
    J Vasc Surg; 2011 Sep; 54(3 Suppl):12S-4S. PubMed ID: 21872108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Financial relationships of institutional review board members.
    Miller FG
    N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710
    [No Abstract]   [Full Text] [Related]  

  • 52. Ethics and Industry Interactions: Impact on Specialty Training, Clinical Practice, and Research.
    Kang JS
    Rheum Dis Clin North Am; 2020 Feb; 46(1):119-133. PubMed ID: 31757280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing financial conflicts of interest.
    IRB; 2003; 25(1):7. PubMed ID: 12833898
    [No Abstract]   [Full Text] [Related]  

  • 54. Expedited industry-sponsored translational research: a seductive but hazardous cocktail?
    Marks JH
    Am J Bioeth; 2008 Mar; 8(3):56-8; discussion W1-3. PubMed ID: 18570106
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 57. Commercial support for continuing medical education.
    Mamdani MB; Mamdani B
    Issues Med Ethics; 1997; 5(2):43-5. PubMed ID: 16267900
    [No Abstract]   [Full Text] [Related]  

  • 58. Independent investigators and for-profit companies. Guidelines for biomedical scientists considering funding by industry.
    Chren MM
    Arch Dermatol; 1994 Apr; 130(4):432-7. PubMed ID: 8166481
    [No Abstract]   [Full Text] [Related]  

  • 59. Continuing medical education--limiting industry's influence.
    Fonseca R
    N Engl J Med; 2010 Mar; 362(11):1053; author reply 1053-4. PubMed ID: 20301802
    [No Abstract]   [Full Text] [Related]  

  • 60. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.